Trial
NCT05031481
Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis.
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
EMS
Collaborators
—
Condition
Vulvovaginal Candidiasis
Intervention
Venus 20 + 0,064
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-10